These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35948379)

  • 1. Outcome disparities in patients with atrial fibrillation based on insurance plan and educational attainment: a nationwide, multicenter and prospective cohort trial.
    Apiyasawat S; Thongsri T; Jongpiputvanich K; Krittayaphong R;
    BMJ Open; 2022 Aug; 12(8):e053166. PubMed ID: 35948379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of gender on the clinical outcomes of Asian non-valvular atrial fibrillation patients: insights from the prospective multicentre COOL-AF registry.
    Krittayaphong R; Phrommintikul A; Winijkul A; Methavigul K; Komoltri C; Kaewkumdee P; Yindeengam A;
    BMJ Open; 2021 May; 11(5):e043862. PubMed ID: 33958338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants: A Randomized Clinical Trial.
    Pokorney SD; Cocoros N; Al-Khalidi HR; Haynes K; Li S; Al-Khatib SM; Corrigan-Curay J; Driscoll MR; Garcia C; Calvert SB; Harkins T; Jin R; Knecht D; Levenson M; Lin ND; Martin D; McCall D; McMahill-Walraven C; Nair V; Parlett L; Petrone A; Temple R; Zhang R; Zhou Y; Platt R; Granger CB
    JAMA Netw Open; 2022 May; 5(5):e2214321. PubMed ID: 35639381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry.
    Ding WY; Proietti M; Boriani G; Fauchier L; Blomström-Lundqvist C; Marin F; Potpara TS; Lip GYH;
    Europace; 2022 May; 24(5):721-728. PubMed ID: 35446354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation.
    Chu G; Seelig J; Trinks-Roerdink EM; van Alem AP; Alings M; van den Bemt B; Boersma LV; Brouwer MA; Cannegieter SC; Ten Cate H; Kirchhof CJ; Crijns HJ; van Dijk EJ; Elvan A; van Gelder IC; de Groot JR; den Hartog FR; de Jong JS; de Jong S; Klok FA; Lenderink T; Luermans JG; Meeder JG; Pisters R; Polak P; Rienstra M; Smeets F; Tahapary GJ; Theunissen L; Tieleman RG; Trines SA; van der Voort P; Geersing GJ; Rutten FH; Hemels ME; Huisman MV
    BMJ Open; 2020 Aug; 10(8):e036220. PubMed ID: 32843516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world data on the incidence, mortality, and cost of ischaemic stroke and major bleeding events among non-valvular atrial fibrillation patients in England.
    Bakhai A; Petri H; Vahidnia F; Wolf C; Ding Y; Foskett N; Sculpher M
    J Eval Clin Pract; 2021 Feb; 27(1):119-133. PubMed ID: 32314853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
    JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcomes after major bleeding in patients with atrial fibrillation: the Fushimi AF registry.
    Ogawa H; An Y; Ishigami K; Ikeda S; Doi K; Hamatani Y; Fujino A; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GYH; Akao M;
    Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):163-171. PubMed ID: 33107912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
    Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry.
    Bakhai A; Darius H; De Caterina R; Smart A; Le Heuzey JY; Schilling RJ; Zamorano JL; Shah M; Bramlage P; Kirchhof P
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):299-305. PubMed ID: 29474715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    Steinberg BA; Kim S; Thomas L; Fonarow GC; Hylek E; Ansell J; Go AS; Chang P; Kowey P; Gersh BJ; Mahaffey KW; Singer DE; Piccini JP; Peterson ED;
    Circulation; 2014 May; 129(20):2005-12. PubMed ID: 24682387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GARFIELD-AF model for prediction of stroke and major bleeding in atrial fibrillation: a Danish nationwide validation study.
    Dalgaard F; Pieper K; Verheugt F; Camm AJ; Fox KA; Kakkar AK; Pallisgaard JL; Rasmussen PV; Weert HV; Lindhardt TB; Torp-Pedersen C; Gislason GH; Ruwald MH; Harskamp RE
    BMJ Open; 2019 Nov; 9(11):e033283. PubMed ID: 31719095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
    O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality risk and temporal patterns of atrial fibrillation in the nationwide registry.
    Apiyasawat S; Kornbongkotmas S; Chichareon P; Krittayaphong R;
    J Arrhythm; 2021 Dec; 37(6):1434-1442. PubMed ID: 34887947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry.
    Bertomeu-Gonzalez V; Moreno-Arribas J; Esteve-Pastor MA; Roldán-Rabadán I; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
    J Am Heart Assoc; 2020 Jan; 9(1):e013789. PubMed ID: 31870235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.
    Pokorney SD; Holmes DN; Thomas L; Fonarow GC; Kowey PR; Reiffel JA; Singer DE; Freeman JV; Gersh BJ; Mahaffey KW; Hylek EM; Naccarelli GV; Ezekowitz MD; Piccini JP; Peterson ED;
    JAMA Cardiol; 2019 Aug; 4(8):756-764. PubMed ID: 31268487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    Larsen TB; Skjøth F; Nielsen PB; Kjældgaard JN; Lip GY
    BMJ; 2016 Jun; 353():i3189. PubMed ID: 27312796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study.
    Yoon M; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Sung JH; Pak HN; Lee MH; Joung B; Lip GYH
    Thromb Haemost; 2019 Oct; 119(10):1695-1703. PubMed ID: 31266082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.